心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2020 ESH共识声明：原发性醛固酮增多症的遗传学，流行，筛查和确认

2020-09-05 欧洲高血压学会 J Hypertens . 2020 Oct;38(10):1919-1928.

原发性醛固酮增多症

2020年欧洲高血压学会(ESH)发布了原发性醛固酮增多症的遗传学，流行，筛查和确认共识声明。约有5%-10%的高血压患者为自发性醛固酮分泌过多，原发性醛固酮增多症的诊断主要基于激素水平测试，来自ES

中文标题：

2020 ESH共识声明：原发性醛固酮增多症的遗传学，流行，筛查和确认

英文标题：

Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension

发布机构：

欧洲高血压学会

发布日期：

2020-09-05

简要介绍：

2020年欧洲高血压学会(ESH)发布了原发性醛固酮增多症的遗传学，流行，筛查和确认共识声明。约有5%-10%的高血压患者为自发性醛固酮分泌过多，原发性醛固酮增多症的诊断主要基于激素水平测试，来自ESH的专家主要针对原发性醛固酮增多症的流行病学，诊断治疗以及并发症的相关内容进行总结，最终形成两篇共识文章。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ESH共识声明：原发性醛固酮增多症的遗传学，流行，筛查和确认.pdf)] GetToolGuiderByIdResponse(projectId=1, id=bddb41c0019ea63a, title=2020 ESH共识声明：原发性醛固酮增多症的遗传学，流行，筛查和确认, enTitle=Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension, guiderFrom=J Hypertens . 2020 Oct;38(10):1919-1928., authorId=0, author=, summary=2020年欧洲高血压学会(ESH)发布了原发性醛固酮增多症的遗传学，流行，筛查和确认共识声明。约有5%-10%的高血压患者为自发性醛固酮分泌过多，原发性醛固酮增多症的诊断主要基于激素水平测试，来自ES, cover=https://img.medsci.cn/2020923/1600870957407_2020535.jpg, journalId=0, articlesId=null, associationId=633, associationName=欧洲高血压学会, associationIntro=null, copyright=0, guiderPublishedTime=Sat Sep 05 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年欧洲高血压学会(ESH)发布了原发性醛固酮增多症的遗传学，流行，筛查和确认共识声明。约有5%-10%的高血压患者为自发性醛固酮分泌过多，原发性醛固酮增多症的诊断主要基于激素水平测试，来自ESH的专家主要针对原发性醛固酮增多症的流行病学，诊断治疗以及并发症的相关内容进行总结，最终形成两篇共识文章。</p> </div> </div> </div>, tagList=[TagDto(tagId=3308, tagName=原发性醛固酮增多症)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3308, guiderKeyword=原发性醛固酮增多症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3334, appHits=294, showAppHits=0, pcHits=838, showPcHits=3040, likes=2, shares=10, comments=13, approvalStatus=1, publishedTime=Wed Sep 23 23:08:53 CST 2020, publishedTimeString=2020-09-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Sep 23 22:22:49 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:23:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ESH共识声明：原发性醛固酮增多症的遗传学，流行，筛查和确认.pdf)])
2020 ESH共识声明：原发性醛固酮增多症的遗传学，流行，筛查和确认.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1070221, encodeId=0c7e10e022133, content=很好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49175530021, createdName=ms5000001605845118, createdTime=Sun Nov 14 19:45:49 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054389, encodeId=38d2105438998, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ed5170417, createdName=146d6392m68暂无昵称, createdTime=Fri Sep 24 09:22:33 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009697, encodeId=2650100969e41, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53395112243, createdName=14619de3m24暂无昵称, createdTime=Fri Aug 20 12:30:05 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973697, encodeId=a2f29e3697a7, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e8a5480521, createdName=ms8000000656093431, createdTime=Tue Jun 15 12:07:36 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962669, encodeId=dc48962669e5, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Tue May 04 19:46:31 CST 2021, time=2021-05-04, status=1, ipAttribution=)]
    2021-11-14 ms5000001605845118

    很好👍

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1070221, encodeId=0c7e10e022133, content=很好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49175530021, createdName=ms5000001605845118, createdTime=Sun Nov 14 19:45:49 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054389, encodeId=38d2105438998, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ed5170417, createdName=146d6392m68暂无昵称, createdTime=Fri Sep 24 09:22:33 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009697, encodeId=2650100969e41, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53395112243, createdName=14619de3m24暂无昵称, createdTime=Fri Aug 20 12:30:05 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973697, encodeId=a2f29e3697a7, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e8a5480521, createdName=ms8000000656093431, createdTime=Tue Jun 15 12:07:36 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962669, encodeId=dc48962669e5, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Tue May 04 19:46:31 CST 2021, time=2021-05-04, status=1, ipAttribution=)]
    2021-09-24 146d6392m68暂无昵称

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1070221, encodeId=0c7e10e022133, content=很好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49175530021, createdName=ms5000001605845118, createdTime=Sun Nov 14 19:45:49 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054389, encodeId=38d2105438998, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ed5170417, createdName=146d6392m68暂无昵称, createdTime=Fri Sep 24 09:22:33 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009697, encodeId=2650100969e41, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53395112243, createdName=14619de3m24暂无昵称, createdTime=Fri Aug 20 12:30:05 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973697, encodeId=a2f29e3697a7, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e8a5480521, createdName=ms8000000656093431, createdTime=Tue Jun 15 12:07:36 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962669, encodeId=dc48962669e5, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Tue May 04 19:46:31 CST 2021, time=2021-05-04, status=1, ipAttribution=)]
    2021-08-20 14619de3m24暂无昵称

    很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1070221, encodeId=0c7e10e022133, content=很好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49175530021, createdName=ms5000001605845118, createdTime=Sun Nov 14 19:45:49 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054389, encodeId=38d2105438998, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ed5170417, createdName=146d6392m68暂无昵称, createdTime=Fri Sep 24 09:22:33 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009697, encodeId=2650100969e41, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53395112243, createdName=14619de3m24暂无昵称, createdTime=Fri Aug 20 12:30:05 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973697, encodeId=a2f29e3697a7, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e8a5480521, createdName=ms8000000656093431, createdTime=Tue Jun 15 12:07:36 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962669, encodeId=dc48962669e5, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Tue May 04 19:46:31 CST 2021, time=2021-05-04, status=1, ipAttribution=)]
    2021-06-15 ms8000000656093431

    感谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1070221, encodeId=0c7e10e022133, content=很好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49175530021, createdName=ms5000001605845118, createdTime=Sun Nov 14 19:45:49 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054389, encodeId=38d2105438998, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99ed5170417, createdName=146d6392m68暂无昵称, createdTime=Fri Sep 24 09:22:33 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009697, encodeId=2650100969e41, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53395112243, createdName=14619de3m24暂无昵称, createdTime=Fri Aug 20 12:30:05 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973697, encodeId=a2f29e3697a7, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e8a5480521, createdName=ms8000000656093431, createdTime=Tue Jun 15 12:07:36 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962669, encodeId=dc48962669e5, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/54886e9842d0997b08ed3f134c538d9d.jpg, createdBy=0d1e1365885, createdName=yesaisai133, createdTime=Tue May 04 19:46:31 CST 2021, time=2021-05-04, status=1, ipAttribution=)]
    2021-05-04 yesaisai133

    很好

    0

相关指南

原发性醛固酮增多症的遗传学，患病率，筛查和确认：欧洲高血压学会内分泌高血压工作组的立场声明和共识

欧洲高血压学会(ESH,European Society of Hypertension) · 2020-09-09

原发性醛固酮增多症的亚型诊断，治疗，并发症和结局以及未来的研究方向：欧洲高血压学会内分泌高血压工作组的立场声明和共识

欧洲高血压学会(ESH,European Society of Hypertension) · 2020-09-08

2016 原发性醛固酮增多症诊断治疗的专家共识

中华医学会内分泌学分会(CSE,Chinese Society of Endocrinology) · 2016-03-30

2009 JES指南：原发性醛固酮增多症的诊断和治疗

暂未更新 · 2011-08-09